Suchergebnisse - "Schimmer, Roman R"

PubPharm (5)

1

Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells

enthalten in: EMBO molecular medicine | 2024

von Mueller, J. | Schimmer, R. | Koch, C. | +14

2

Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells

enthalten in: EMBO Molecular Medicine | 2024

von Mueller, J. | Schimmer, R. | Koch, C. | +14

3

Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab

enthalten in: British journal of haematology | 2024

von Schimmer, R. | Sutter, T. | Bachofner, A. | +6

4

Targeted Large-Volume Lymphocyte Removal Using Magnetic Nanoparticles in Blood Samples of Patients with Chronic Lymphocytic Leukemia : A Proof-of-Concept Study

enthalten in: International journal of molecular sciences | 2023

von Janker, S. | Doswald, S. | Schimmer, R. | +4

5

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms

enthalten in: Blood advances | 2022

von Schimmer, R. | Kovtonyuk, L. | Klemm, N. | +8

1
[1]